Production of high titer attenuated poliovirus strains on the serum-free PER.C6® cell culture platform for the generation of safe and affordable next generation IPV-Reference-Cited by-同舟云学术

Production of high titer attenuated poliovirus strains on the serum-free PER.C6® cell culture platform for the generation of safe and affordable next generation IPV

Published:2015-11 Issue:48 Volume:33 Page:6611-6616
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Sanders Barbara P.,Oakes Isabel de los Rios,van Hoek Vladimir,Liu Ying,Marissen Wilfred,Minor Philip D.,Wimmer Eckard,Schuitemaker Hanneke,Custers Jerome H.H.V.,Macadam Andrew,Cello Jeronimo,Edo-Matas Diana

Funder

Johnson & Johnson

Bill and Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference40 articles.

1. GPEI. History of Polio: http://www.polioeradication.org/Polioandprevention/Historyofpolio.aspx. 2015.

2. Properties and behavior of orally administered attenuated poliovirus vaccine;Sabin;JAMA,1957

3. Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines;Salk;Am J Public Health Nations Health,1954

4. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis;Pliaka;Expert Rev Vaccines,2012

5. Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication;Minor;Vaccine,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antigenic diversity of type 1 polioviruses and its implications for the efficacy of polio vaccines;Vaccine;2023-03

2. Polio and Its Epidemiology;Infectious Diseases;2023

3. Poliovirus Vaccine—Inactivated;Plotkin's Vaccines;2023

4. Promising opportunities to improve polio vaccines;Biological Products. Prevention, Diagnosis, Treatment;2022-07-02

5. Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age;Human Vaccines & Immunotherapeutics;2022-03-28